6.16
前日終値:
$6.70
開ける:
$6.67
24時間の取引高:
1.54M
Relative Volume:
0.92
時価総額:
$2.63B
収益:
$1.21B
当期純損益:
$-95.29M
株価収益率:
-23.69
EPS:
-0.26
ネットキャッシュフロー:
$35.06M
1週間 パフォーマンス:
-10.07%
1か月 パフォーマンス:
-10.07%
6か月 パフォーマンス:
-12.50%
1年 パフォーマンス:
+7.88%
Lifestance Health Group Inc Stock (LFST) Company Profile
名前
Lifestance Health Group Inc
セクター
電話
602-767-2100
住所
4800 N. SCOTTSDALE ROAD, SCOTTSDALE
LFST を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
LFST
Lifestance Health Group Inc
|
6.16 | 2.63B | 1.21B | -95.29M | 35.06M | -0.26 |
![]()
HCA
Hca Healthcare Inc
|
317.61 | 83.86B | 70.60B | 5.76B | 5.64B | 21.97 |
![]()
FMS
Fresenius Medical Care Ag Adr
|
23.52 | 14.48B | 20.87B | 715.14M | 1.67B | 1.2209 |
![]()
DVA
Davita Inc
|
133.50 | 11.70B | 12.67B | 827.68M | 1.42B | 9.27 |
![]()
UHS
Universal Health Services Inc
|
157.05 | 11.66B | 15.42B | 1.03B | 956.84M | 15.02 |
![]()
THC
Tenet Healthcare Corp
|
110.41 | 10.88B | 20.97B | 3.13B | 2.39B | 31.21 |
Lifestance Health Group Inc Stock (LFST) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-04-08 | 開始されました | KeyBanc Capital Markets | Overweight |
2025-04-03 | 開始されました | Canaccord Genuity | Buy |
2024-12-16 | アップグレード | Goldman | Neutral → Buy |
2024-01-03 | 開始されました | Barclays | Underweight |
2023-05-15 | ダウングレード | TD Cowen | Outperform → Market Perform |
2023-01-06 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2022-11-07 | 再開されました | Jefferies | Buy |
2022-03-17 | ダウングレード | UBS | Buy → Neutral |
2021-11-09 | ダウングレード | JP Morgan | Overweight → Neutral |
2021-09-10 | 開始されました | Cowen | Outperform |
2021-08-16 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2021-07-06 | 開始されました | Goldman | Neutral |
2021-07-06 | 開始されました | JP Morgan | Overweight |
2021-07-06 | 開始されました | Jefferies | Buy |
2021-07-06 | 開始されました | Morgan Stanley | Overweight |
2021-07-06 | 開始されました | William Blair | Outperform |
すべてを表示
Lifestance Health Group Inc (LFST) 最新ニュース
LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025 - GlobeNewswire
Mental Health Giant LifeStance Sets Q1 2025 Earnings Release: Key Details for Investors - Stock Titan
RXO, The Ensign Group, LifeStance Health Group, Surgery Partners, and Guardant Health Stocks Trade Down, What You Need To Know - Yahoo
3 Healthcare Stocks with Questionable Fundamentals - Yahoo Finance
Why LFST Is A Stock To Watch - RTTNews
3 Reasons LFST is Risky and 1 Stock to Buy Instead - Yahoo Finance
LifeStance Survey Finds Nearly One-Third of Americans Use Social Media Content to Self-Diagnose Mental Health Conditions - marketscreener.com
LifeStance Survey Finds Nearly One-Third of Americans Use Social Media Content to Self-Diagnose Mental Health Conditions – Company AnnouncementFT.com - Financial Times
Lifestance health director Robert Bessler sells $34,447 in shares By Investing.com - Investing.com South Africa
Lifestance health director Robert Bessler sells $34,447 in shares - Investing.com Australia
Addus HomeCare (ADUS) Surges 4.9%: Is This an Indication of Further Gains? - Yahoo Finance
LifeStance Health (LFST) Surges 5.8%: Is This an Indication of Further Gains? - Yahoo Finance
Wall Street Analysts See a 26.63% Upside in LifeStance Health (LFST): Can the Stock Really Move This High? - Yahoo Finance
LifeStance Health Group (NASDAQ:LFST) Upgraded at KeyCorp - Defense World
LifeStance Health's SWOT analysis: hybrid model drives growth amid mental health surge - Investing.com
Keybanc Initiates Coverage of LifeStance Health Group (LFST) with Overweight Recommendation - MSN
LifeStance Health’s SWOT analysis: hybrid model drives growth amid mental health surge - Investing.com India
LifeStance Health wins bullish view at KeyBanc on growth prospects - MSN
LifeStance stock rated overweight at KeyBanc (LFST:NASDAQ) - Seeking Alpha
KeyBanc Initiates Lifestance Health Group at Overweight With $9 Price Target - MarketScreener
KeyBanc starts Lifestance Health with Overweight rating By Investing.com - Investing.com South Africa
KeyBanc starts Lifestance Health with Overweight rating - Investing.com Australia
(LFST) Proactive Strategies - news.stocktradersdaily.com
Press Release Distribution & PR Platform - ACCESS Newswire
LifeStance Health Group, Inc. (LFST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
This Talkspace Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday - Benzinga
LifeStance to Present at the 22nd Annual Morgan Stanley Healthcare Conference - Quantisnow
April 2025's Leading Growth Companies With High Insider Ownership - simplywall.st
When Will LifeStance Health Group, Inc. (NASDAQ:LFST) Become Profitable? - Yahoo Finance
LifeStance Health (LFST) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
LifeStance Health Group (NASDAQ:LFST) Is Carrying A Fair Bit Of Debt - simplywall.st
LifeStance Health EVP Lisa K. Miller sells $130,030 in stock By Investing.com - Investing.com Australia
Top Executive Sells Thousands of Lifestance Health Group Shares - TipRanks
LifeStance Health EVP Lisa K. Miller sells $130,030 in stock - Investing.com India
How to Take Advantage of moves in (LFST) - news.stocktradersdaily.com
A significant driver of top-line growth: LifeStance Health Group Inc (LFST) - SETE News
LifeStance Health Group’s chief digital officer sells $264,293 in stock By Investing.com - Investing.com Australia
Outpatient & Specialty Care Stocks Q4 Results: Benchmarking U.S. Physical Therapy (NYSE:USPH) - The Globe and Mail
LifeStance Health Group’s chief digital officer sells $264,293 in stock - Investing.com India
LifeStance Health Group Enters Oversold Territory (LFST) - Nasdaq
(LFST) Investment Analysis and Advice - Stock Traders Daily
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies LifeStance Health Group, Inc. (LFST) Investors of Class Action and to Actively Participate - ACCESS Newswire
LifeStance Health’s Earnings Call Highlights Strong Growth - TipRanks
March 2025 Growth Companies With Strong Insider Confidence - Simply Wall St
UBS Adjusts Price Target on Lifestance Health Group to $8.50 From $7.50, Maintains Neutral Rating - Marketscreener.com
LifeStance Health Group, Inc. (NASDAQ:LFST) Q4 2024 Earnings Call Transcript - MSN
LifeStance Health Group’s (LFST) Outperform Rating Reiterated at William Blair - Defense World
Lifestance Health Group Inc (LFST) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):